Vaccines - Malawi

Malawi

The Vaccines market in Malawi is expected to witness significant growth in the coming years.
According to projections, the market's revenue is estimated to reach US$37.92m by 2024.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of -13.52% from 2024 to 2029.
As a result, the market volume is forecasted to expand to US$18.34m by the end of 2029.
In terms of global comparison, United States is expected to dominate the Vaccines market, generating the highest revenue of US$29,120.00m in 2024.
This showcases the significant market potential and importance of the United States in the global Vaccines market industry.
Malawi is experiencing an increasing demand for vaccines due to the rising awareness of the importance of immunization.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

Malawi is a country in southeastern Africa, bordered by Tanzania, Zambia, and Mozambique. The Vaccines market in Malawi has been developing at a steady pace in recent years, driven by several factors.

Customer preferences: In Malawi, the demand for vaccines has been increasing due to the growing awareness about the importance of immunization. The government has been actively promoting vaccination programs to prevent the spread of diseases such as measles, polio, and tuberculosis. Additionally, the rise in the number of private healthcare facilities has also contributed to the growth of the vaccines market in the country.

Trends in the market: One of the major trends in the vaccines market in Malawi is the increasing use of combination vaccines. Combination vaccines are a mixture of several vaccines in a single shot, which helps to reduce the number of injections required for immunization. This has led to increased convenience and cost-effectiveness for patients and healthcare providers. Another trend is the growing demand for vaccines for non-communicable diseases such as cancer and diabetes.

Local special circumstances: Malawi faces several challenges in its healthcare system, including a shortage of healthcare workers, inadequate infrastructure, and limited financial resources. These challenges have made it difficult to provide adequate healthcare services, including vaccination programs, to the entire population. As a result, the government has been working with international organizations to improve the country's healthcare system and increase access to vaccines.

Underlying macroeconomic factors: Malawi is one of the poorest countries in the world, with a largely agricultural economy. The country has been heavily dependent on foreign aid to support its development, including its healthcare system. However, the government has been making efforts to diversify the economy and reduce its reliance on foreign aid. This has led to increased investment in the healthcare sector, including the vaccines market.In conclusion, the vaccines market in Malawi has been growing steadily in recent years, driven by increasing customer awareness and demand, the use of combination vaccines, and government efforts to improve the healthcare system. Despite the challenges faced by the country's healthcare system, the vaccines market is expected to continue to grow in the coming years as the government and international organizations work to address these challenges.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.